Streetbeat News

Analyst Ratings

THO

Benchmark analyst Michael Albanese has reiterated a Hold rating on Thor Industries (NYSE:THO).

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:07 pm

LH

Piper Sandler has initiated coverage on Labcorp Holdings with a Neutral rating and set a price target of $235.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:04 pm

PLXS

Benchmark analyst David Williams has maintained a Buy rating on Plexus (NASDAQ:PLXS) and raised the price target from $145 to $150.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:02 pm

LULU

Over the past three months, 30 analysts have evaluated Lululemon Athletica (NASDAQ:LULU), showing a range of sentiments from bullish to bearish. The average 12-month price target has decreased by 14.64% to $320.83, with a high of $470.00 and a low of $220.00. Recent analyst actions include several downgrades and lowered price targets, reflecting a negative shift in sentiment. Despite this, Lululemon's financial performance remains strong, with impressive revenue growth, net margin, ROE, and ROA, and a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 12:02 pm

GOOG

Analysts have varied ratings for Alphabet (NASDAQ:GOOG), ranging from bullish to somewhat bullish. Recent evaluations show an upward trend in price targets, with an average target of $207.5. Alphabet's financials reveal strong revenue growth, high net margins, and efficient asset management.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 12:01 pm

VRTX

Analysts have varied opinions on Vertex Pharmaceuticals (NASDAQ:VRTX), with recent ratings showing a mix of bullish and bearish sentiments. The average 12-month price target has increased by 8.29% to $500.53. Vertex's financials reveal a positive revenue trend but challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 12:01 pm

ACMR

ACM Research (NASDAQ:ACMR) has been analyzed by 5 analysts, showing a range of bullish to bearish perspectives. The average 12-month price target is $31.8, down 5.92% from the previous $33.80. Analysts maintain mostly 'Buy' ratings, with some adjustments in price targets. ACM Research has shown a 40.05% revenue growth but faces challenges with below-average net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 12:01 pm

MGM

Analysts have mixed ratings for MGM Resorts Intl (NYSE:MGM), with a recent decrease in average price targets by 2.19%. The company's financial performance shows strong revenue growth and net margin, but challenges in asset utilization and high debt levels.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 12:00 pm

PAGS

PagSeguro Digital (NYSE:PAGS) has received mixed analyst ratings, with a recent decrease in average price target by 22.7%. Analysts have varied opinions, ranging from 'Market Perform' to 'Underweight', with price targets between $6.50 and $16.00. The company's financial performance shows strong net margins but challenges in ROE and ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 12:00 pm

ANEB

Benchmark analyst Robert Wasserman has reiterated a Speculative Buy rating on Anebulo Pharmaceuticals (NASDAQ:ANEB) and maintained a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 11:54 am